Background
Danny Ray Lujan was committed to the Colorado Mental Health Hospital in Pueblo after being found incompetent to proceed in three criminal cases. He was diagnosed with an unspecified schizophrenia spectrum disorder and experienced paranoid delusions, auditory hallucinations, and anger. He initially declined antipsychotic medication, although he accepted an antidepressant for sleep.
After several escalating incidents in which Lujan threatened or assaulted hospital staff, the hospital began an emergency course of Zyprexa and Depakote. The State then sought authorization to administer those drugs as well as Risperdal and Haldol without Lujan’s consent. Following an evidentiary hearing, the district court found that the State had proved all four requirements of People v. Medina by clear and convincing evidence and granted the petition.
The Court’s Holding
The Colorado Court of Appeals affirmed. It held that the record supported the district court’s findings that involuntary medication was necessary both to prevent significant and likely long-term deterioration in Lujan’s mental condition and to prevent likely serious harm to others in the hospital. The treating psychiatrist’s testimony, credited by the district court, supported those findings, including testimony about Lujan’s persistent symptoms, recent assaults, and risk of continued aggression without treatment.
The court also held that the authorization of Risperdal and Haldol, including as alternative or backup medications, was supported by evidence that Lujan had limited treatment history and that his team needed flexibility to identify effective and tolerable medication without delays that could endanger staff. Although the district court erred insofar as it found Lujan’s concern about medication side effects was not a bona fide and legitimate reason to refuse treatment, that error did not require reversal. The evidence supported the further finding that his prognosis without treatment was sufficiently unfavorable to outweigh his refusal interest.
Key Takeaways
- A treating psychiatrist’s credited testimony may suffice to support an involuntary-medication order under Medina.
- Alternative and backup medications may be authorized when the treatment team lacks enough history to know which option will be effective and needs flexibility to protect institutional safety.
- Medication side effects are a legitimate basis for refusal, but the State may still prevail if the need for treatment outweighs that interest.
Why It Matters
The decision confirms that a medication order may rest on both branches of Medina’s second element: preventing long-term psychiatric deterioration and preventing likely serious harm within the institution. It also applies recent Colorado authority allowing a reasonably defined set of medication alternatives when clinical uncertainty makes a single-drug order impractical.